Bioptimus

🚀 Introducing H-optimus-1: the leading foundation model for histology, developed by Bioptimus. Trained on over 1 million whole-slide images from 800,000+ patients, H-optimus-1 sets a new performance benchmark in computational pathology. It outperforms existing models across key tasks—including tissue type classification, tumor grading, and biomarker prediction—spanning over 50 organs. The model is advancing precision medicine and research through critical applications, such as: 🧬 Biomarker discovery & patient stratification 💊 Drug discovery & preclinical validation 👩🔬 Accelerating clinical trials & regulatory approvals 🔬 Enhancing digital pathology & AI-assisted diagnosis H-optimus-1 is the first step in our mission to build a multi-scale, multimodal foundation model for biology. By integrating histology with other biological data types, breaking down silos in biology to give us a full understanding we aim to unlock the next generation of AI-powered precision medicine. Learn more about H-optimus-1: https://lnkd.in/etbBDgSK Explore our multimodal foundation model: https://lnkd.in/e_Hreivt

🎉 We're thrilled to welcome Julie Gerardi as Bioptimus's first Chief Commercial Officer! A biotech industry veteran with 25+ years of experience, Julie has been part of building pioneering life science businesses across the most exciting and fast-growing biotech startups and Fortune 500 companies, like Parse, Tempus, Definiens and Astra Zeneca. Julie will spearhead our mission to transform how biological research and drug development are conducted, driving strategic partnerships and commercial initiatives that will bring the power of foundation models to the global life sciences community. Welcome to the team, Julie! 🧬 #Bioptimus #AIforBiology #FoundationModels #Biotech

🗓️ Happening today at 13:30 CEST. We look forward to the discussion with our co-founder, Felipe Llinares-López, and COO, Mathilda Strom, at the Foundational Models in Biology webinar. There is still time to join the conversation live: https://lnkd.in/dEAZfRyb #FoundationModels #Biotechnology #AIinBiology

Our co-founder, Felipe Llinares-López, and COO, Mathilda Strom, will be featured speakers at Plug and Play Health upcoming webinar, Foundational Models in Biology, on July 9th. Join them and other leading experts from Helmholtz Munich and World Fund to explore how powerful models such as M-optimus and H-optimus-1 are accelerating breakthroughs in life sciences, from drug discovery to personalized medicine. 🔗 Register here to attend: https://lnkd.in/dEAZfRyb #FoundationModels #Biotechnology #AIinBiology

🤖 We're launching a new function at Bioptimus: AI Operations. We're thrilled to welcome exceptional talents Ricardo Eleutério de Oliveira and Hector Parmantier, ML engineers with multi-functional skillsets honed through consulting and start-ups. They'll be working alongside our COO Mathilda Strom to build this new critical function from the ground up. Our vision for #Operations at Bioptimus is straightforward: build a team of agents and people that keeps us fast, radically efficient, and focused on our end goal. We're creating #agentic workflows across all #automatable parts of the business, freeing our people to focus on what only they can do—the complex judgment calls that build #foundationmodels to drive #breakthroughs in #biology. Building the future of biology requires rethinking everything, including how we work. #FutureofWork #FoundationModelsforBiology #AIOperations

🌍 Shortly after the acceptance of our H0-mini paper in collaboration with OWKIN for MICCAI Society 2025, we want to celebrate the academic community from +100 institutions across the world that are now using H-optimus-1 and H0-mini to advance biological research. From leading academic labs in Europe, North America, and Asia, to emerging research hubs in Africa and Latin America, we’re proud to enable discovery across borders and empower scientists at the frontlines of cancer research around the world. At Bioptimus, we’re committed to giving back to the community where it all began — by providing the tools we need to accelerate biology freely for research use through academic licensing. 🔬 Are you using our H-* models in your research? We’d love to hear what you’re working on. 🔗 https://lnkd.in/eBXRTgXQ 🔗 https://lnkd.in/dcBhQJbs 🗞️ https://lnkd.in/eSpKqyZw #Bioptimus #AIforBiology #FoundationModels #DigitalPathology

🕺 Excited to share that #Bioptimus has secured significant #compute power from NVIDIA DGX Cloud Lepton! Through a collaboration between NVIDIA and our investor Sofinnova Partners, we’ve gained free early access to DGX Cloud Lepton, NVIDIA’s new global compute platform — giving us the infrastructure we need to accelerate our breakthrough multimodal, multiscale foundation model for biology - a collaboration potentially worth multiple millions. As a company working with sensitive and large-scale biological data, the ability to scale compute while keeping data local is crucial. DGX Cloud Lepton gives us both the flexibility and performance to move faster than ever before. We’re proud to be among the first to build on this platform — and excited to help shape the future of biological AI. Read more 🔗: https://lnkd.in/e4ZPd8r4

Bioptimus is in full force at #VivaTech2025 in Paris this week! 🧬 June 12: 10am - Our Founding COO Mathilda Strom will be joining Nina Mian (AstraZeneca), Nicolás L. (InstaDeep), Jacky Abitbol (Cathay Innovation) and Mariam Zaidi (TRT World) to talk about "AI-powered drug innovation: from discovery to development" Meanwhile, our co-founder and VP of Research Zelda Mariet will be killing it on two panels: 🚀 June 12: 10am Panel "How AI is propelling BioTech into a new era" with Philippe Gesnouin and Valerian Guestre 🐈⬛ June 13 : 5pm - "What will healthcare look like tomorrow?" with Bertrand Duplat and Rosalie MAURISSE 🤹♀️ In case you need more, Zelda and Mathilda will also be manning the Bioptimus booth at La French Tech on Friday the 13th 👻 AND 🦾 Our co-founder and VP of AI, Felipe Llinares-López will be joining NVIDIA and other AI leaders in a closed workshop on Thursday June 12th AND 🍹 Our CEO Jean-Philippe Vert will be attending various breakfasts and dinners and attending the Viva Technology & Founders Forum Group events at #LeWeekend HASHTAG #WhenTechComeToOurHomeTown #FoundationModels #FoundationModelsforBiology #AIforBiology

Our first paper has been accepted to MICCAI 2025! Earlier this year we built a distilled version of our world-leading, open-source histopathology "H-0" model in collaboration with OWKIN. We called it "H0-mini" 🤏 📄 Our paper (written together with Owkin) shows how distillation techniques can shrink the size of foundation models for histopathology by several orders of magnitude while preserving performance and improving robustness. A critical step toward practical, scalable digital pathology. 🔗 https://lnkd.in/eSpKqyZw

🎉 We're honoured to be selected for the La French Tech #Next40/120 program for 2025! This recognition places Bioptimus among the most promising and high-impact technology companies in France, and strengthens our momentum as we work to transform biology with AI. Bioptimus is building the world’s first multi-scale foundation model for biology, combining large-scale AI with biological data to capture the complexity of life and fuel biomedical breakthroughs. This support from the French government will help accelerate our mission on a #global scale. 🚀 #TransformBiology #FoundationModels #Biology #AIforBiology #BiologyFoundationModels